1. bookVolume 17 (2011): Issue 3 (September 2011)
Journal Details
License
Format
Journal
eISSN
1898-0309
First Published
30 Dec 2008
Publication timeframe
4 times per year
Languages
English
access type Open Access

Dosimetry of two new interstitial brachytherapy sources

Published Online: 20 Mar 2012
Volume & Issue: Volume 17 (2011) - Issue 3 (September 2011)
Page range: 129 - 141
Journal Details
License
Format
Journal
eISSN
1898-0309
First Published
30 Dec 2008
Publication timeframe
4 times per year
Languages
English
Dosimetry of two new interstitial brachytherapy sources

With increased demand for low 103Pd (palladium) seed sources, to treat prostate and eye cancers, new sources have been designed and introduced. This article presents the two new palladium brachytherapy sources, IR03-103Pd and IR04-103Pd that have been developed at Nuclear Science and Technology Research Institute. The dosimetry parameters such as the dose rate constant Λ, the radial dose function g(r), and the anisotropy function F(r,θ), around the sources have been characterized using Version 5 Monte Carlo radiation transport code in accordance with the update AAPM Task Group No. 43 report (TG-43U1). The results indicated the dose rate constant of 0.689±0.02 and 0.667±0.02 cGy h-1 U-1 for the IR03-103Pd and IR04-103Pd sources respectively, which are in acceptable agreement with other commercial seeds. The calculated results were compared with published results for those of other source manufacturers. However, they show an acceptable dose distribution, using for clinical applications is pending experimental dosimetry.

Keywords

Cross section Evaluation Working Group, "ENDF/B-VI Summary documentation (ENDF-201)", Brookhaven National Laboratory Report No. BNL.NCS-17541, 8th ed., National Nuclear Data Center, (December 2000).Search in Google Scholar

Gearheart DM, Drogin A, Sowards K, Meigooni AS, Ibbott GS. Dosimetric characteristics of a new 125I brachytherapy source. Med Phys. 2000; 27: 2278-2285.10.1118/1.129048611099194Search in Google Scholar

http://www.nea.fr/abs/html/ccc-0740.htmlSearch in Google Scholar

Kouwenhoven E, Laarse R, Schaart DR. Variation in interpretation of the AAPM TG-43 geometry factor leads to unclearness in brachytherapy dosimetry. Med Phys 2001; 28: 1965-1966.10.1118/1.139856311585228Search in Google Scholar

Li Z, Palta JR, Fan JJ. Monte Carlo calculations and experimental measurements of dosimetry parameters of a new 103Pd source. Med Phys. 2000; 27: 1108-1112.10.1118/1.59897510841416Search in Google Scholar

Li Z. Monte Carlo calculation of dosimetry parameters of the Urcor Prostaseed 125I source. Med Phys. 2000; 29: 2278-2285.Search in Google Scholar

Meigooni AS, Bharucha Z, Yoe-Sein M, Sowards K. Dosimetric characteristic of the best double -wall 103Pd brachytherapy source. Med Phys. 2001; 28: 2568-2575.10.1118/1.141400711797962Search in Google Scholar

Melhus CS, Rivard MJ. COMS eye plaque brachytherapy dosimetry simulations for 103Pd, 125I, and 131Cs. Med Phys. 2008; 35: 3364-3371.10.1118/1.294060428513032Search in Google Scholar

Monte Carlo Team, MCNP-A General Monte Carlo N-Particle Transport Code - Version 5, Los Alamos National Laboratory http://mcnp-green.lanl.gov/index.htmlSearch in Google Scholar

Murali V, Kurup PGG, Mahadev P, Mahalakshmi S. Dosimetric analysis and comparison of IMRT and HDR brachytherapy in treatment of localized prostate cancer. J Med Phys. 2010; 35: 113-119.10.4103/0971-6203.62201288430320589121Search in Google Scholar

Nath R, Anderson LL, Luxton G, Weaver KA, Williamson JF, Meigooni AS. Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No.43. American Association of Physicists in Medicine. Med Phys. 1995; 22: 209-234.10.1118/1.5974587565352Search in Google Scholar

Nath R, Yue N, Shahnazi K, Bongiorni PJ. Measurement of dose-rate constant for 103Pd seeds with air-kerma strength calibration based upon a primary national standard. Med Phys. 2000; 27: 655-658.10.1118/1.59892510798685Search in Google Scholar

Popescu CC, Wise J, Sowards K, Meigooni AS, Ibbott GS. Dosimetric characteristic of the Pharma Seed model BT-125-I source. Med Phys. 2000; 27: 2174-2181.10.1118/1.128989711011748Search in Google Scholar

Raisali Gh, Ghonchehnazi MG, Shokrani P, Sadeghi M. Monte Carlo and experimental characterization of the first AMIRS 103Pd brachytherapy. Appl Radiat Isot. 2008: 66: 1856-1860.10.1016/j.apradiso.2008.06.00718657981Search in Google Scholar

Rivard MJ, Coursey BM, DeWerd LA, Hanson WF, Huq MS, Ibbott GS, Mitch MG, Nath R, Williamson JF. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations. Med Phys. 2004; 31: 633-674.10.1118/1.164604015070264Search in Google Scholar

Rivard MJ. Monte Carlo calculation of AAPM Task Group Report No.43 dosimetry parameters for the MED3631-A/M 125I source. Med Phys. 2001; 28: 629-637.10.1118/1.135530611339761Search in Google Scholar

Sadeghi M, Hosseini SH, Raisali Gh. Experimental measurements and Monte Carlo calculations of dosimetric parameters of the IRA1-103Pd brachytherapy source. Appl Radiat Isot 2008; 66: 1431-1437.10.1016/j.apradiso.2008.02.08118387806Search in Google Scholar

Sadeghi M, Raisali Gh, Hosseini SH, Shahvar A. Monte Carlo calculations and experimental measurements of dosimetric parameters of the IRA-103Pd brachytherapy source. Med Phys. 2008; 35: 1288-1294.10.1118/1.287022918491522Search in Google Scholar

Saidi P, Sadeghi M, Shirazi A, Tenreiro C. Monte Carlo calculation of dosimetry parameters for the IR08-103Pd brachytherapy source. Med Phys. 2010; 37: 2509-2515.10.1118/1.341692220632562Search in Google Scholar

Wallace RE, Fan JJ. Dosimetric characterization of a new design 103-palladium brachytherapy source. Med Phys. 1999; 26: 2465-2470.10.1118/1.59876510587234Search in Google Scholar

Williamson JF. Monte Carlo modeling of the transverse-axis dose distribution of the model 200 103Pd interstitial brachytherapy source. Med Phys. 2000; 27: 643-654.10.1118/1.59892410798684Search in Google Scholar

Zhang H, Martin D, Chiu-Tsao S, Meigooni A, Thomadsen B. A comprehensive dosimetric between 131Cs and 125I brachytherapy sources for COMS eye plaque implant. Brachytherapy 2010; 9: 362-372.10.1016/j.brachy.2009.07.00720116342Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo